Insider · CIK 0002127496
Lana Gladstein
Files at SPTX (Seaport Therapeutics, Inc.). First filing -, latest -.
In brief
Lana Gladstein files SEC Form 4 as officer at SPTX (Seaport Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lana Gladstein has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | SPTX Seaport Therapeutics, Inc. | CConversion Common Stock | +33,515 | - | - | 33,515 | May 4, 2026 |
| Apr 30, 2026 | SPTX Seaport Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +63,680 | $0.00 | $0 | 63,680 | May 4, 2026 |
| May 4, 2026 | SPTX Seaport Therapeutics, Inc. | CConversion Series B Preferred Stockderivative | -105,263 | $0.00 | $0 | 0 | May 4, 2026 |
Questions about Lana Gladstein
Answered from the filings on this page, as of the latest one.
Is Lana Gladstein buying or selling?
Lana Gladstein has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lana Gladstein's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lana Gladstein has 0.
Where does Lana Gladstein file Form 4?
Lana Gladstein has filed Form 4 at SPTX (Seaport Therapeutics, Inc.) as General Counsel. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.